Abstract: CTLA-8 antigen from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said antigen. Methods of using said reagents and diagnostic kits are also provided.
Type:
Grant
Filed:
August 13, 2001
Date of Patent:
March 16, 2004
Assignees:
Inserm, Institut National de la Sante et de la Recherche
Medicale, Schering Corporation
Inventors:
Pierre Golstein, Eric Rouvier, Francois Fossiez, Serge J. E. Lebecque, Odile Djossou, Jacques Banchereau
Abstract: Nucleic acids encoding mammalian, e.g., primate, IL-1&zgr;, purified IL-1&zgr; polypeptides and fragments thereof. Binding proteins, e.g., antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.
Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
Type:
Grant
Filed:
April 17, 2001
Date of Patent:
January 13, 2004
Assignee:
Schering Corporation
Inventors:
Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
Abstract: Methods for increasing yields of regulatory T cells, useful, e.g., in transplantation contexts. Use of antigen presenting cells and anti-CD28 are also described.
Type:
Grant
Filed:
October 3, 2001
Date of Patent:
December 30, 2003
Assignee:
Schering Corporation
Inventors:
Franck J. Barrat, Pieter Andre Boonstra, Huub Savelkoul, Rene de Waal Malefyt, Anne O'Garra
Abstract: Nucleic acids encoding various proteases, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
Type:
Grant
Filed:
August 29, 2000
Date of Patent:
October 28, 2003
Assignee:
Schering Corporation
Inventors:
Sriram Balasubramanian, John Ford, Daniel M. Gorman, Gerard Zurawski
Abstract: Nucleic acids encoding mammalian, e.g., primate or rodent receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.
Type:
Grant
Filed:
March 8, 1999
Date of Patent:
July 1, 2003
Assignee:
Schering Corporation
Inventors:
Christi L. Parham, Kevin W. Moore, Nicholas J. Murgolo
Abstract: IL-17-like cytokines from mammals, reagents and diagnostic kits related thereto including purified proteins, specific antibodies, and nucleic acids are provided. Methods of using the reagents and diagnostic kits are also provided.
Type:
Grant
Filed:
January 10, 2000
Date of Patent:
May 13, 2003
Assignee:
Schering Corporation
Inventors:
Daniel M. Gorman, J. Fernando Bazan, Robert A. Kastelein
Abstract: Nucleic acids encoding various proteases, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
Type:
Grant
Filed:
April 10, 2000
Date of Patent:
February 11, 2003
Assignee:
Schering Corporation
Inventors:
Lynette M. Dowling, Constance F. Huffine, Daniel M. Gorman
Abstract: Nucleic acids encoding various monocyte cell proteins from a primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using reagents relating to nucleic acids encoding monocyte cell proteins, and diagnostic kits, are also provided.
Type:
Grant
Filed:
April 10, 2000
Date of Patent:
November 12, 2002
Assignee:
Schering Corporation
Inventors:
Gosse Jan Adema, Linde Meyaard, Daniel M. Gorman, Terrill K. McClanahan, Sandra M. Zurawski, Gerard Zurawski, Lewis L. Lanier, Joseph H. Phillips, Jr.
Abstract: This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells.
Type:
Grant
Filed:
December 8, 1999
Date of Patent:
May 28, 2002
Assignee:
Schering Corporation
Inventors:
Joseph A. Hedrick, Susan A. Hudak, Donna M. Rennick, Albert Zlotnik